Market Cap | ₹25Cr |
ROE | 8.05% |
P/E Ratio(TTM) | 24.27 |
EPS(TTM) | 3.42 |
P/B Ratio | 2.30 |
Dividend Yield | 0.00% |
Industry P/E | 40.50 |
Book Value | 36.08 |
Debt to Equity | 0.36 |
Face Value | 10 |
Parent Organisation | Ishita Drugs & Industries Limited |
Managing Director | Mr. Jagdish Agrawal |
BSE Symbol | 524400 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Divi's Laboratories | NA (0.00%) | 68.88 | ||
Neuland Laboratories | NA (0.00%) | 109.42 | ||
Jubilant Pharmova | NA (0.00%) | 37.25 | ||
Acutaas Chemicals | NA (0.00%) | 62.30 |